FineTech Laboratories
1990
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
5
FINANCING ROUNDS
Description
Developer of active pharmaceutical ingredients created to process and polymorph patents by developing non-infringing processes or polymorphs. The company's active pharmaceutical ingredients include cabergoline, latanoprost, travoprost, nabilone, melatonin and methylbenzethonium chloride, enabling the healthcare sectors to access a wide range of products and services to fulfill their needs and develop their sectors under one roof.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
- 33, Hanarkissim Street
- Nesher 36608
- Israel
FineTech Laboratories Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore FineTech Laboratories‘s full profile, request access.
Request full access to PitchBookFineTech Laboratories Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore FineTech Laboratories‘s full profile, request access.
Request full access to PitchBook